- Home
- Equipment
- netherlands
- transplanter
Show results for
Refine by
Transplanter Equipment Supplied In Netherlands
6 equipment items found
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
K-NK002: A phase 2 clinical study evaluating haplo-identical NK cells to prevent post-transplant relapse in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This study was designed based on promising clinical proof-of-concept data from MD Anderson Cancer Center. The phase 2 trial for K-NK002 will be conducted in collaboration with the Bone Marrow ...
Manufactured by:The Surgical Company B.V. based inAmersfoort, NETHERLANDS
The Fluido Trauma Set is ideal for flow rates up to ...
Manufactured by:The Surgical Company B.V. based inAmersfoort, NETHERLANDS
The Fluido Trauma Plus Set is ideal for flow rates up to ...
Manufactured by:CuraMedical B.V. based inAssendelft, NETHERLANDS
Oxidised Renegerated Cellulose Natural, plant based cellulose is dissolved and extruded as a continuous fibre (regeneration). The fabric made from the fibre is very uniform in chemical composition and its oxidation results in less variation in stability and absorbility of the material compared to cotton based products. CuraCel® Absorbable Haemostat is a sterile product made of oxidized ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Tafasitamab (MOR208) is a humanized FC-modified CD19 targeting immunotherapy in clinical development for the treatment of B cell malignancies. CD19 is broadly expressed on the surface of B cells. It is therefore considered as a potential target for the treatment of B cell malignancies, such as non-Hodgkin’s lymphoma (NHL), including diffuse large B cell lymphoma (DLBCL), indolent lymphomas ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
Ushering in the Future of NK-cell Therapy: Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases.1 Today, we ...